DESCRIPTION

This presentation will be a clinically driven overview on schizophrenia spectrum disorders. Mood disorders with psychotic features will be used to highlight the differential diagnoses of schizophrenia spectrum disorders, and misdiagnoses of Black patients. The discussion will address the management of psychotic disorders, including refractory psychosis, as well as side effects of medication management, such as tardive dyskinesia.

LEARNING OBJECTIVES

• Describe the features of psychosis
• Distinguish psychotic disorders from affective and other disorders presenting with psychosis in the Black community
• Describe the general framework of medication management
• Discuss side effects of medication management such as tardive dyskinesia
• Identify barriers to the access of mental health services  
• Become familiar with resources for patient referral, family psychoeducation, and community support 

PRESENTER

Dr. Ikwunga Wonodi is a Service Chief in the adult service line at Sheppard Pratt’s new Baltimore Washington Campus. He is an Adjunct Associate Professor at the Maryland Psychiatric Research Center (MPRC), University of Maryland School of Medicine. Dr. Wonodi is the Treasurer of the Black Psychiatrists of America and has over 20 years of experience working with individuals with psychotic disorders. His primary research interests have focused on schizophrenia-related genomic markers, as well as biomarkers related to antipsychotic medication response and adverse effects in individuals of African ancestry. His interests also include healthcare management, education, and behavioral health equity.

HOST

Annelle Primm, M.D., MPH is the Senior Medical Director of the Steve Fund, an organization focused on the mental health of young people of color. She is also a member of the Black Psychiatrists of America Council of Elders.

AUDIENCE

Mental health clinicians, peer supporters, community services staff, and the general public